- Barclays raised the price target on Burlington Stores, Inc. BURL from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to $189.87 in pre-market trading.
- Wedbush cut the price target for Jack in the Box Inc. JACK from $115 to $100. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Jack in the Box shares fell 16.1% to close at $71.24 on Tuesday.
- Barclays cut the price target on Arvinas, Inc. ARVN from $90 to $70. Arvinas shares fell 5.5% to close at $40.70 on Tuesday.
- Bernstein boosted the price target for Analog Devices, Inc. ADI from $190 to $200. Analog Devices shares gained 0.9% to $169.98 in pre-market trading.
- Piper Sandler slashed the price target for Teva Pharmaceutical Industries Limited TEVA from $8 to $7. Teva Pharmaceutical shares fell 0.7% to $8.91 in pre-market trading.
- Citigroup cut the price target on MacroGenics, Inc. MGNX from $16 to $7. MacroGenics shares gained 2.7% to $6.35 in pre-market trading.
- Wells Fargo boosted the price target on Zimmer Biomet Holdings, Inc. ZBH from $116 to $124. Zimmer Biomet shares rose 1.6% to $117.22 in pre-market trading.
Check out this: Market Volatility Decreases Further After US Stocks Record Gains
Don’t forget to check out our premarket coverage here .
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in